Literature DB >> 1423846

Expression of ras oncogene mRNA and protein in aberrant crypt foci.

S A Stopera1, R P Bird.   

Abstract

The expression of the ras oncogene in aberrant crypt foci was studied by both in situ hybridization and immunohistochemical approaches. Aberrant crypt foci are hypothesized to represent the earliest identifiable microscopic lesions of colon cancer in rodent colons. Sprague-Dawley male rats were injected with azoxymethane (20 mg/kg s.c.) once. Twelve weeks later, aberrant crypt foci were identified topographically, microdissected and processed for histology. In situ hybridization with an antisense oligomer of c-ras demonstrated increased expression of ras-specific RNA in aberrant crypts compared to normal crypts. A low amount of non-specific hybridization was obtained with the corresponding sense oligomer. The percentage of cells with grains (labeling index) was calculated in early and advanced aberrant crypt foci. This index was also calculated in normal appearing crypts. The labeling indices for the early and advanced aberrant crypt foci were significantly greater than that of normal crypts (18.0 and 25.0 versus 11.9). In the same tissue specimens, immunohistochemical staining for ras p21 with the monoclonal antibody (Y13-259) revealed strong staining intensity in early aberrant crypts (15/22) and advanced aberrant crypts (22/30) compared to normal crypts (3/50). The immunohistochemical results demonstrate the presence of elevated levels of ras p21 in the same tissue as increased levels of ras-specific message. This investigation provides the earliest demonstration of increased expression of the ras oncogene in precursor lesions of colon cancer possessing dysplastic features.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423846     DOI: 10.1093/carcin/13.10.1863

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

Review 1.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

2.  Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability.

Authors:  Helen Swede; Thomas E Rohan; Herbert Yu; Joseph C Anderson; Richard G Stevens; Jane Brokaw; Joel Levine; Bruce M Brenner; Carl D Malchoff; Valerie B Duffy; Devon C Pleau; Daniel W Rosenberg
Journal:  Cancer Causes Control       Date:  2008-12-09       Impact factor: 2.506

3.  Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts.

Authors:  Y Fujimitsu; H Nakanishi; K Inada; T Yamachika; M Ichinose; H Fukami; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1996-12

4.  Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats.

Authors:  Rehan Khan; Abdul Quaiyoom Khan; Abdul Lateef; Muneeb U Rehman; Mir Tahir; Farrah Ali; Oday O Hamiza; Sarwat Sultana
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

5.  Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis.

Authors:  G Caderni; A Giannini; L Lancioni; C Luceri; A Biggeri; P Dolara
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

6.  Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.

Authors:  N Yamashita; T Minamoto; M Onda; H Esumi
Journal:  Jpn J Cancer Res       Date:  1994-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.